Pages that link to "Q53927447"

The following pages link to Paroxetine pharmacokinetics in depressed children and adolescents. (Q53927447):

Displaying 21 items.

• Anxiety and mood disorders in children and adolescents: A practice update (Q33595645) (← links)
• Selective serotonin reuptake inhibitors for children and adolescents (Q34108327) (← links)
• The pharmacological treatment of anxiety disorders in children and adolescents (Q34628617) (← links)
• Reversing the myths obstructing the determination of optimal age- and disease-based drug dosing in pediatrics (Q35104991) (← links)
• Childhood anxiety disorders and developmental issues in anxiety. (Q35176158) (← links)
• A review of antidepressant-induced hypomania in major depression: suggestions for DSM-V. (Q35680384) (← links)
• The role of 5-HT1A receptors in mediating acute negative effects of antidepressants: implications in pediatric depression (Q35753190) (← links)
• Paroxetine: population pharmacokinetic analysis in late-life depression using sparse concentration sampling (Q35827538) (← links)
• Assessment of adolescent neurotoxicity: rationale and methodological considerations (Q35891388) (← links)
• Exposure-outcome analysis in depressed patients treated with paroxetine using population pharmacokinetics (Q36079358) (← links)
• Selective serotonin reuptake inhibitors for children and adolescents with major depression: current controversies and recommendations (Q36195126) (← links)
• Research in child and adolescent psychopharmacology: recent accomplishments and new challenges (Q36485658) (← links)
• Psychopharmacologic treatment of pediatric major depressive disorder (Q36560433) (← links)
• Hypotension following cardiac surgery associated with paroxetine and mirtazapine withdrawal (Q41882784) (← links)
• Pharmacokinetics of orally administered duloxetine in children and adolescents with major depressive disorder (Q42669945) (← links)
• Multiple dose pharmacokinetics of paroxetine in children and adolescents with major depressive disorder or obsessive-compulsive disorder (Q42674455) (← links)
• Antidepressant tolerability in anxious and depressed youth at high risk for bipolar disorder: a prospective naturalistic treatment study. (Q47990576) (← links)
• Somatic treatment for depressive illnesses in children and adolescents (Q79867000) (← links)
• Toward precision medicine in pediatric population using cytochrome P450 phenotyping approaches and physiologically based pharmacokinetic modeling (Q90631903) (← links)
• A Review of Antidepressant-Associated Hypomania in Those Diagnosed with Unipolar Depression-Risk Factors, Conceptual Models, and Management (Q90676426) (← links)
• Paroxetine induced mania in pre-adolescence (Q92205841) (← links)